EcoDrugPlus

Aryl Hydrocarbon Receptor

Ensembl ID : ENSBGRG00000002193
Gene Symbol: AHR
1 Cross references
155 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSBGRG00000011397
Gene Symbol: AURKA
1 Cross references
233 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSBGRG00000026727
Gene Symbol: AURKB
1 Cross references
205 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSBGRG00000025124
Gene Symbol: BACE1
1 Cross references
220 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSBGRG00000017462
Gene Symbol: BDKRB1
1 Cross references
149 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSBGRG00000017338
Gene Symbol: BDKRB2
1 Cross references
362 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSBGRG00000009941
Gene Symbol: BCHE
1 Cross references
130 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSBGRG00000003080
Gene Symbol: CALCRL
1 Cross references
149 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSBGRG00000004818
Gene Symbol: CASR
1 Cross references
203 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 1

Ensembl ID : ENSBGRG00000020514
Gene Symbol: CACNA2D1
1 Cross references
287 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 2

Ensembl ID : ENSBGRG00000024741
Gene Symbol: CACNA2D2
1 Cross references
269 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 3

Ensembl ID : ENSBGRG00000021687
Gene Symbol: CACNA2D3
1 Cross references
213 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).